SOPH Q3 2024 Earnings — SOPHiA GENETICS S.A. Revenue & Financial Results | Market Cap Arena

SOPHSOPHiA GENETICS S.A.

$308M

Q3 2024 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$16M-2.8% YoY

Gross Profit

$11M67.2% margin

Operating Income

-$15M-96.9% margin

Net Income

-$18M-116.3% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

+0.3%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$9M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$178M

Total Liabilities

$64M

Stockholders' Equity

$114M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$16M	-2.8%
Gross Profit	$11M	$11M	-5.5%
Operating Income	-$15M	-$17M	+7.1%
Net Income	-$18M	-$14M	-33.4%